Biosimulation Market Size, Share, Growth, Trends and Industry Research Report, 2018 to 2024

The global biosimulation market size was estimated at USD 1.20 billion in 2016. It is expected to expand at a noteworthy CAGR of 15.4%%%% over the forecast period. Mounting cases of drug relapse due to acquired drug resistance in diseases such as cancer, tuberculosis, and other bacterial infections are among the key trends stimulating market growth. This is estimated to drive clinical urgency to incorporate biosimulation in initial development of new generation of drugs.